TGA Approval

SOLU-CORTEF ACT-O-VIAL hydrocortisone (as sodium succinate) 250mg powder for injection and diluent dual-chamber vial (167894)

ARTG ID

167894

ARTG Name

SOLU-CORTEF ACT-O-VIAL hydrocortisone (as sodium succinate) 250mg powder for injection and diluent dual-chamber vial

Sponsor

Pfizer Australia Pty Ltd

ARTG Date

March 5, 2010

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

PFIZER AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/c9be4b8b08432099b5e69434250d8a0d.pdf

https://medical-cdn.nocode.com/drug_tga/dde7324578643d817e1e6b3be5281e91.pdf

Ingredient Name

hydrocortisone sodium succinate

Empowering clinical research with data-driven insights and AI-powered tools.

SOLU-CORTEF ACT-O-VIAL hydrocortisone (as sodium succinate) 250mg powder for injection and diluent dual-chamber vial (167894) - TGA 批准文号 | MedPath